tiprankstipranks
Trending News
More News >
Ensysce Biosciences (ENSC)
NASDAQ:ENSC
US Market
Advertisement

Ensysce Biosciences (ENSC) Stock Statistics & Valuation Metrics

Compare
288 Followers

Total Valuation

Ensysce Biosciences has a market cap or net worth of $6.20M. The enterprise value is $2.77M.
Market Cap$6.20M
Enterprise Value$2.77M

Share Statistics

Ensysce Biosciences has 2,968,444 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,968,444
Owned by Insiders
Owned by Institutions5.54%

Financial Efficiency

Ensysce Biosciences’s return on equity (ROE) is -2.15 and return on invested capital (ROIC) is -182.30%.
Return on Equity (ROE)-2.15
Return on Assets (ROA)-1.43
Return on Invested Capital (ROIC)-182.30%
Return on Capital Employed (ROCE)-1.99
Revenue Per Employee744.29K
Profits Per Employee-1.14M
Employee Count7
Asset Turnover0.93
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Ensysce Biosciences is ―. Ensysce Biosciences’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value3.83
Price to FCF
Price to Operating Cash Flow-0.74
PEG Ratio

Income Statement

In the last 12 months, Ensysce Biosciences had revenue of 5.21M and earned -7.99M in profits. Earnings per share was -4.57.
Revenue5.21M
Gross Profit-2.01M
Operating Income-6.73M
Pretax Income-7.99M
Net Income-7.99M
EBITDA-6.73M
Earnings Per Share (EPS)-4.57

Cash Flow

In the last 12 months, operating cash flow was -6.20M and capital expenditures 0.00, giving a free cash flow of -6.20M billion.
Operating Cash Flow-6.20M
Free Cash Flow-6.20M
Free Cash Flow per Share-2.09

Dividends & Yields

Ensysce Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.73
52-Week Price Change-61.86%
50-Day Moving Average2.15
200-Day Moving Average4.35
Relative Strength Index (RSI)48.42
Average Volume (3m)608.05K

Important Dates

Ensysce Biosciences upcoming earnings date is Nov 17, 2025, After Close (Confirmed).
Last Earnings DateAug 13, 2025
Next Earnings DateNov 17, 2025
Ex-Dividend Date

Financial Position

Ensysce Biosciences as a current ratio of 2.42, with Debt / Equity ratio of 12.53%
Current Ratio2.42
Quick Ratio2.42
Debt to Market Cap0.02
Net Debt to EBITDA0.48
Interest Coverage Ratio-5.22

Taxes

In the past 12 months, Ensysce Biosciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Ensysce Biosciences EV to EBITDA ratio is -1.64, with an EV/FCF ratio of >-0.01.
EV to Sales2.12
EV to EBITDA-1.64
EV to Free Cash Flow>-0.01
EV to Operating Cash Flow>-0.01

Balance Sheet

Ensysce Biosciences has $2.21M in cash and marketable securities with $424.52K in debt, giving a net cash position of -$1.79M billion.
Cash & Marketable Securities$2.21M
Total Debt$424.52K
Net Cash-$1.79M
Net Cash Per Share-$0.60
Tangible Book Value Per Share$1.93

Margins

Gross margin is 7.41%, with operating margin of -129.17%, and net profit margin of -153.30%.
Gross Margin7.41%
Operating Margin-129.17%
Pretax Margin-153.30%
Net Profit Margin-153.30%
EBITDA Margin-129.17%
EBIT Margin-129.17%

Analyst Forecast

The average price target for Ensysce Biosciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast415.58%
EPS Growth Forecast90.81%

Scores

Smart ScoreN/A
AI Score31.5
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis